The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.
| 1 | |
Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis |
Curr Ther Res Clin Exp. 2020 Aug 12;93:100601. doi: 10.1016/j.curtheres.2020.100601.eCollection 2020. Dafna D Gladman 1, Ana-Maria Orbai 2, Juan Gomez-Reino 3, Stacey Chang-Douglass 4, Emanuele Leoncini 4, Hannah E Burton 4, Keith S Kanik 5, Ana Belen Romero 6, Joseph C Cappelleri 5, Ming-Ann Hsu 5 |
| 2 | |
Multimorbidity and comorbidity in psoriatic arthritis - a perspective |
Expert Rev Clin Immunol. 2020 Oct;16(10):963-972 doi:10.1080/1744666X.2021.1825941.Epub 2020 Oct 3. Ennio Lubrano 1, Silvia Scriffignano 1, Fabio Massimo Perrotta 1 |
| 3 | |
Linking the patient experience of foot involvement related to psoriatic arthritis to the International Classification of Functioning, Disability and Health |
Rheumatol Adv Pract. 2020 Jul 11;4(2):rkaa028. doi: 10.1093/rap/rkaa028. eCollection 2020. Kate Carter 1, Caterina Tannous 2, Steven Walmsley 1, Keith Rome 3, Deborah E Turner 1 4 |
| 4 | |
Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies |
ACR Open Rheumatol. 2020 Oct;2(10):543-554. doi: 10.1002/acr2.11166. Epub 2020 Sep 10. Christopher T Ritchlin 1, Jon T Giles 2, Alexis Ogdie 3, Juan J Gomez-Reino 4, Philip Helliwell 5, Pamela Young 6, Cunshan Wang 7, Joseph Wu 7, Ana Belén Romero 8, John Woolcott 6, Lori Stockert 6 |
| 5 | |
Histological Evaluation of the Relationships Between Distal Interphalangeal Psoriatic Arthritis and Nail Psoriasis: Correlations With Anatomical Studies of the Normal Nail Unit and the Main Radiological Data Concerning Distal Interphalangeal Psoriatic Arthritis |
Am J Dermatopathol. 2020 Dec;42(12):911-915. doi: 10.1097/DAD.0000000000001786. |
| 6 | |
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis |
Rheumatology (Oxford). 2021 Mar 2;60(3):1137-1147. doi: 10.1093/rheumatology/keaa271. Laura C Coates 1, Joseph F Merola 2, Philip J Mease 3, Alexis Ogdie 4, Dafna D Gladman 5, Vibeke Strand 6, Leonieke J J van Mens 7, Lyrica Liu 8, Priscilla K Yen 9, David H Collier 10, Gregory Kricorian 10, James B Chung 10, Philip S Helliwell 11 |
| 7 | |
Barriers to shared decision-making with women of reproductive age affected by a chronic inflammatory disease: a mixed-methods needs assessment of dermatologists and rheumatologists |
BMJ Open. 2021 Jun 16;11(6):e043960. doi: 10.1136/bmjopen-2020-043960. Suzanne Murray 1, Monica Augustyniak 2, Jenny E Murase 3 4, Rebecca Fischer-Betz 5, Catherine Nelson-Piercy 6, Morgan Peniuta 2, Ivo Vlaev 7 |
| 8 | |
Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFa, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study |
Clin Rheumatol. 2021 Jun 16. doi: 10.1007/s10067-021-05799-0. Online ahead of print. Mariagrazia Lorenzin # 1, Augusta Ortolan # 1, Giacomo Cozzi 1, Antonia Calligaro 1, Maria Favaro 1, Teresa Del Ross 1, Andrea Doria 1, Roberta Ramonda 2 |
| 9 | |
Measurement of minimal disease activity in psoriatic arthritis using PROMIS-Physical Function or the Health Assessment Questionnaire-Disability Index |
Arthritis Care Res (Hoboken). 2020 Aug 29;10.1002/acr.24433. doi: 10.1002/acr.24433.Online ahead of print. Erin Chew 1 2, Jamie Perin 3, Thomas Grader-Beck 1, Ana-Maria Orbai 1 |
| 10 | |
Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates |
Arthritis Res Ther. 2020 Aug 26;22(1):198. doi: 10.1186/s13075-020-02294-w. Glenn Haugeberg 1 2, Mari Hoff 3, Arthur Kavanaugh 4, Brigitte Michelsen 5 |
| 11 | |
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration |
Ann Rheum Dis. 2021 Jun 3;annrheumdis-2021-220097.doi: 10.1136/annrheumdis-2021-220097. Online ahead of print. Ulf Lindström 1, Daniela Di Giuseppe 2, Bénédicte Delcoigne 2, Bente Glintborg 3 4, Burkhard Möller 5, Adrian Ciurea 6, Manuel Pombo-Suarez 7, Carlos Sanchez-Piedra 8, Kari Eklund 9 10, Heikki Relas 9, Bjorn Gudbjornsson 11 12, Thorvardur Jon Love 12 13, Gareth T Jones 14, Catalin Codreanu 15, Ruxandra Ionescu 16, Lucie Nekvindova 17 18, Jakub Závada 19 20, Nuh Atas 21, Servet Yolbas 22, Karen Minde Fagerli 23, Brigitte Michelsen 23 24, Žiga Rotar 25 26, Matija Tomšic 25 26, Florenzo Iannone 27, Maria Jose Santos 28, Pedro Avila-Ribeiro 29 30, Lykke Midtbøll Ørnbjerg 31, Mikkel Østergaard 31 32, Lennart Th Jacobsson 33, Johan Askling 2, Michael J Nissen 34 |
| 12 | |
Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis |
Int J Rheum Dis. 2021 Jun 2. doi: 10.1111/1756-185X.14147. Online ahead of print. Aravinthan Loganathan 1 2 3, Narainraj Kamalaraj 1 4, Carlos El-Haddad 1, Kevin Pile 1 3 |
| 13 | |
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting |
J Rheumatol Suppl. 2021 Jun;97:65-66. doi: 10.3899/jrheum.201681. Laura C Coates 1, Nadia Corp 2, Danielle A van der Windt 2, Enrique R Soriano 3, Arthur Kavanaugh 4 |
| 14 | |
GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting |
J Rheumatol Suppl. 2021 Jun;97:64. doi: 10.3899/jrheum.201680. |
| 15 | |
Development of a national survey on foot involvement among people with psoriatic arthritis in Australia using a best practice approach: a survey development protocol |
J Foot Ankle Res. 2020 Aug 26;13(1):53. doi: 10.1186/s13047-020-00424-w. Kate Carter 1, Steven Walmsley 2, Keith Rome 3, Deborah E Turner 4 |
| 16 | |
Development and Validation of a Sonographic Enthesitis Instrument in Psoriatic Arthritis: The GRAPPA Diagnostic Ultrasound Enthesitis Tool (DUET) Project |
J Rheumatol Suppl. 2020 Jun;96:50-52. doi: 10.3899/jrheum.200128. |
| 17 | |
JAK inhibitors, Psoriatic Arthritis, and Axial Spondyloarthritis: a Critical Review of Clinical Trials |
Expert Rev Clin Immunol. 2021 May 4. doi: 10.1080/1744666X.2021.1925541.Online ahead of print. |
| 18 | |
Updated therapies for the management of Psoriatic Arthritis |
Clin Immunol. 2020 Nov;220:108536. doi: 10.1016/j.clim.2020.108536.Epub 2020 Jul 16. Atrin Toussi 1, Natalia Maverakis 2, Stephanie T Le 3, Soumajyoti Sarkar 4, Smriti K Raychaudhuri 5, Siba P Raychaudhuri 6 |
| 19 | |
Test-retest reliability for HAQ-DI and SF-36 PF for the measurement of physical function in psoriatic arthritis |
J Rheumatol. 2021 Apr 15;jrheum.210175. doi: 10.3899/jrheum.210175. Online ahead of print. Ying Ying Leung 1, William Tillett 1, Pil Hojgaard 1, Ana-Maria Orbai 1, Richard Holland 1, Ashish J Mathew 1, Niti Goel 1, Jeffrey Chau 1, Chris Lindsay 1, Alexis Ogdie 1, Laura C Coates 1, Robin Christensen 1, Philip Mease 1, Vibeke Strand 1, Dafna D Gladman 1 |
| 20 | |
Pregnancy in women with psoriatic arthritis: A systematic literature review of disease activity and adverse pregnancy outcomes |
Semin Arthritis Rheum. 2021 Apr 15;51(3):530-538.doi: 10.1016/j.semarthrit.2021.04.003. Online ahead of print. Yvette Meissner 1, Tatjana Rudi 2, Rebecca Fischer-Betz 3, Anja Strangfeld 2 |
| 21 | |
The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data |
Br J Dermatol. 2021 Apr 8. doi: 10.1111/bjd.20136. Online ahead of print. M Lebwohl 1, A Deodhar 2, C E M Griffiths 3, M A Menter 4, D Poddubnyy 5, W Bao 6, V Jehl 7, K Marfo 7, P Primatesta 7, A Shete 7, V Trivedi 6, P J Mease 8 |
| 22 | |
GRAPPA Treatment Recommendations: Updates and Methods |
J Rheumatol Suppl. 2020 Jun;96:41-45. doi: 10.3899/jrheum.200126. Arthur Kavanaugh 1 2, Laura C Coates 3 4, Danielle A van der Windt 3 4, Nadia Corp 3 4, Enrique R Soriano 3 4 |
| 23 | |
Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study |
Rheumatol Ther. 2020 Sep;7(3):553-580.doi: 10.1007/s40744-020-00209-4. Epub 2020 Jun 6. Peter Nash 1, Laura C Coates 2, Alan J Kivitz 3, Philip J Mease 4, Dafna D Gladman 5, José A Covarrubias-Cobos 6, Oliver FitzGerald 7, Dona Fleishaker 8, Cunshan Wang 8, Joseph Wu 8, Ming-Ann Hsu 8, Sujatha Menon 8, Lara Fallon 9, Ana Belén Romero 10, Keith S Kanik 8 |
| 24 | |
Methotrexate in Psoriasis and Psoriatic Arthritis |
J Rheumatol Suppl. 2020 Jun;96:31-35. doi: 10.3899/jrheum.200124. Laura C Coates 1 2 3, Joseph F Merola 4 5 6, Suzanne M Grieb 4 5 6, Philip J Mease 4 5 6, Kristina Callis Duffin 4 5 6 |
| 25 | |
Resolution of Enthesitis by Guselkumab and Relationships to Disease Burden: 1-Year Results of Two Phase-3 Psoriatic Arthritis Studies |
Rheumatology (Oxford). 2021 Apr 6;keab285. doi: 10.1093/rheumatology/keab285.Online ahead of print. Dennis McGonagle 1, Iain B McInnes 2, Atul Deodhar 3, Georg Schett 4, May Shawi 5, Shelly Kafka 6, Chetan S Karyekar 5, Alexa P Kollmeier 7, Elizabeth C Hsia 7 8, Xie L Xu 7, Shihong Sheng 9, Prasheen Agarwal 9, Bei Zhou 9, Christopher T Ritchlin 10, Proton Rahman 11, Philip J Mease 12 |
| 26 | |
Current treatments and recommendations |
Best Pract Res Clin Rheumatol. 2021 Apr 3;101680. doi: 10.1016/j.berh.2021.101680.Online ahead of print. |
| 27 | |
Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real-world Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry |
J Rheumatol. 2020 Jun 1;jrheum.191117. doi: 10.3899/jrheum.191117. Online ahead of print. Philip J Mease 1, Mei Liu 1, Sabrina Rebello 1, Winnie Hua 1, Robert R McLean 1, Peter Hur 1, Alexis Ogdie 1 |
| 28 | |
Psoriatic arthritis and COVID-19 pandemic: Consequences in medical treatment? |
Dermatol Ther. 2020 Sep;33(5):e13743. doi: 10.1111/dth.13743. Epub 2020 Jun 30. Uwe Wollina 1, Massimo Fioranelli 2, Mohamad Goldust 3 4 5, Torello Lotti 6 |
| 29 | |
Not your average joint: Towards precision medicine in psoriatic arthritis |
Clin Immunol. 2020 Aug;217:108470. doi: 10.1016/j.clim.2020.108470.Epub 2020 May 28. |
| 30 | |
Evaluation of a Genetic Risk Score for Diagnosis of Psoriatic Arthritis |
J Psoriasis Psoriatic Arthritis. 2020 Apr;5(2):61-67. doi: 10.1177/2475530320910814.Epub 2020 Mar 4. Mary Patricia Smith 1, Karen Ly 1, Quinn Thibodeaux 1, Kristen Beck 1, Eric Yang 1 2, Isabelle Sanchez 1 3, Joanne Nititham 1, Tina Bhutani 1, Wilson Liao 1 |
| 31 | |
Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis |
PLoS One. 2020 May 27;15(5):e0233781. doi: 10.1371/journal.pone.0233781.eCollection 2020. Johan Burisch 1, Wolfgang Eigner 2, Stefan Schreiber 3, Daniel Aletaha 4, Wolfgang Weninger 5, Michael Trauner 2, Walter Reinisch 2, Neeraj Narula 6 |
| 32 | |
Costs and Health Outcomes Associated with Tofacitinib Treatment for Active Psoriatic Arthritis in the United States |
J Manag Care Spec Pharm. 2020 Aug;26(8):1027-1038. doi: 10.18553/jmcp.2020.19319.Epub 2020 Apr 20. George Bungey 1, Stacey Chang-Douglass 1, Ming-Ann Hsu 2, Joseph C Cappelleri 2, Pamela Young 3, John Woolcott 3 |
| 33 | |
Real-world 2-year treatment patterns among patients with psoriatic arthritis treated with injectable biologic therapies |
Curr Med Res Opin. 2020 Jul;36(7):1245-1252. doi: 10.1080/03007995.2020.1754186.Epub 2020 Apr 23. Jessica A Walsh 1, Qian Cai 2, Iris Lin 3, Timothy Fitzgerald 3, Christopher D Pericone 2, Soumya D Chakravarty 3 4 |
| 34 | |
Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases |
J Rheumatol. 2021 Jan 1;48(1):48-57. doi: 10.3899/jrheum.190815. Epub 2020 Apr 1. Matthew L Thomas 1, Gavin Shaddick 2, Rachel Charlton 3, Charlotte Cavill 4, Richard Holland 4, Florenzo Iannone 5, Giovanni Lapadula 5, Simona Lopriore 5, Jakub Závada 6, Michal Uher 7, Karel Pavelka 6, Lenka Szczuková 7, Prodromos Sidiropoulos 8, Irini Flouri 8, Alexandros Drosos 9, Burkhard Möller 10, Michael J Nissen 11, Rüdiger B Müller 12, Almut Scherer 13, Neil McHugh 14, Alison Nightingale 15 |
| 35 | |
Psoriatic arthritis in childhood: A commentary on the controversy |
Clin Immunol. 2020 May;214:108396. doi: 10.1016/j.clim.2020.108396.Epub 2020 Mar 27. |
| 36 | |
Challenges in the clinical diagnosis of psoriatic arthritis |
Clin Immunol. 2020 May;214:108390. doi: 10.1016/j.clim.2020.108390.Epub 2020 Mar 18. |
| 37 | |
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial |
Lancet. 2020 Apr 4;395(10230):1126-1136.doi: 10.1016/S0140-6736(20)30263-4. Epub 2020 Mar 13. Philip J Mease 1, Proton Rahman 2, Alice B Gottlieb 3, Alexa P Kollmeier 4, Elizabeth C Hsia 5, Xie L Xu 4, Shihong Sheng 6, Prasheen Agarwal 6, Bei Zhou 6, Yanli Zhuang 7, Désirée van der Heijde 8, Iain B McInnes 9, DISCOVER-2 Study Group |
| 38 | |
Complexities in Genetics of Psoriatic Arthritis |
Curr Rheumatol Rep. 2020 Mar 12;22(4):10. doi: 10.1007/s11926-020-0886-x. Sara Rahmati 1 2, Lam Tsoi 3, Darren O'Rielly 1, Vinod Chandran 1 2 4 5 6, Proton Rahman 7 |
| 39 | |
Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis |
Rheumatology (Oxford). 2020 Sep 1;59(9):2199-2206.doi: 10.1093/rheumatology/keaa062. Bradley Pittam 1, Sonal Gupta 1, Nicholas L Harrison 2, Selina Robertson 1, David M Hughes 3, Sizheng Steven Zhao 2 4 |
| 40 | |
The many faces of psoriatic arthritis: their genetic determinism |
Rheumatology (Oxford). 2020 Mar 1;59(Suppl 1):i4-i9.doi: 10.1093/rheumatology/kez325. |
| 41 | |
Ixekizumab for the treatment of psoriasis: up-to-date |
Expert Opin Biol Ther. 2020 Jun;20(6):549-557.doi: 10.1080/14712598.2020.1729736. Epub 2020 Mar 10. |
| 42 | |
Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis |
Rheumatol Int. 2020 Apr;40(4):511-521. doi: 10.1007/s00296-020-04526-3.Epub 2020 Feb 12. Stephan Pflugbeil 1, Karin Böckl 2, Reinhold Pongratz 1, Marianne Leitner 3, Winfried Graninger 4, Astrid Ortner 5 |
| 43 | |
Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial |
Arthritis Res Ther. 2020 Mar 6;22(1):43. doi: 10.1186/s13075-020-2126-1. Philip Mease 1, M Elaine Husni 2, Shelly Kafka 3, Soumya D Chakravarty 3 4, Diane D Harrison 5, Kim Hung Lo 5, Stephen Xu 5, Elizabeth C Hsia 5 6, Arthur Kavanaugh 7 |
| 44 | |
Identifying and Characterizing Psoriasis and Psoriatic Arthritis Patients in Ontario Administrative Data: A Population-based Study From 1991 to 2015 |
J Rheumatol. 2020 Nov 1;47(11):1644-1651. doi: 10.3899/jrheum.190659. Epub 2020 Feb 15. Lihi Eder 1, Jessica Widdifield 2, Cheryl F Rosen 3, Raed Alhusayen 4, Stephanie Y Cheng 5, Jacqueline Young 5, Willemina Campbell 6, Sasha Bernatsky 7, Dafna D Gladman 8, Michael Paterson 9, Karen Tu 10 |
| 45 | |
Remission in psoriatic arthritis: Definition and predictors |
Semin Arthritis Rheum. 2020 Dec;50(6):1494-1499. doi: 10.1016/j.semarthrit.2020.01.012.Epub 2020 Feb 3. Samar Alharbi 1, Justine Y Ye 2, Ker-Ai Lee 3, Vinod Chandran 4, Richard J Cook 3, Dafna D Gladman 5 |